Rasburicase
Elitek, Fasturtec (rasburicase) is an enzyme pharmaceutical. Rasburicase was first approved as Elitek on 2001-02-23. It is used to treat hyperuricemia and tumor lysis syndrome in the USA. It has been approved in Europe to treat hyperuricemia.
| Trade Name | Fasturtec |
|---|---|
| Common Name | Rasburicase |
| Indication | hyperuricemia, tumor lysis syndrome |
| Drug Class | Enzymes |
